PROTON TRANSFER IMAGING OF GLYCINE IN THE SPINAL CORD
脊髓中甘氨酸的质子转移成像
基本信息
- 批准号:8361977
- 负责人:
- 金额:$ 3.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisBlood flowBrainBrain StemChemicalsClinical ResearchCognition DisordersDetectionDiagnosisDiseaseEnvironmentFundingGlycineGlycine ReceptorsGrantImageIn VitroLocationMagnetic ResonanceMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasurementMeasuresMediatingMethodsModelingMovementNational Center for Research ResourcesNeuraxisNeurotransmittersNuclearParkinson DiseasePathologic ProcessesPathologyPatientsPhysiologicalPrincipal InvestigatorPropertyProteinsProtonsRattusRelaxationResearchResearch InfrastructureResolutionResourcesRetinaSignal TransductionSourceSpinal CordSynapsesSystemTechniquesTestingTimeUnited States National Institutes of HealthWaterWeightattenuationcostin vivomagnetic fieldmotor disorderoptical imagingrelating to nervous system
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Pathologic processes affect the concentrations of certain metabolites or neurotransmitters as well as
local surroundings such as pH and blood flow. Glycine is a neurotransmitter that serves as an
important inhibitory neurotransmitter in the central nervous system. Glycine-dependent synapses
are found to be highly concentrated in the brain stem, retina, and spinal cord. The presence and
location of glycine receptors suggest that glycine signaling might be a key player in the neural
pathology of many motor and cognitive diseases; some notable examples include Amyotrophic
Lateral Sclerosis (ALS), Parkinson's disease, hyperekplexia, and paroxysmal movement.
Measurement of these factors invasively is difficult and may pose more harm to the patient than
benefit. While magnetic resonance spectroscopy (MRS) has previously been used to measure
neurotransmitter concentrations in the central nervous system (CNS), this technique lacks the
adequate spatial resolution to be used in routine clinical studies. The ability to measure such
aspects non-invasively at high resolutions would be a major breakthrough in the diagnoses of
these and many other disorders. Chemical exchange between labile protons of proteins and water
protons can make Magnetic Resonance Imaging (MRI), utilized mainly for the detection of bulk
water signal, sensitive to information about the concentrations of endogenous proteins and their
environments. Recently, a technique called Chemical Exchange Dependent Saturation Transfer
(CEST), which uses the attenuation of bulk water magnetization through magnetization exchange
with saturated labile protons, has been used to characterize properties of dilute labile groups. While
CEST studies have explored numerous metabolites, there have been no studies demonstrating the
CEST effect in glycine. Spin-lattice relaxation in the rotating frame (T1¿) is another contrast
technique that depends on chemical exchange.
There have been no studies to date using T1¿ for contrast in the chemical exchange of protons.
T1¿ Chemical exchange effects vary quadratically with the static magnetic field. Therefore, T1¿
potentially offer higher sensitivity at higher fields in probing exchange mediated interactions in
nuclear spin systems. This higher sensitivity of T1¿ MRI may enable detection of metabolites with
very low concentrations (~1 mM) in the brain.
We hypothesize that it is possible to quantify the CEST effect in glycine at higher magnetic fields
(e3T). Also, that T1¿ MR imaging has higher sensitivity to proton chemical exchange than the
CEST method at ultra-high static fields. Finally, we believe that it is feasible to measure glycine
in vivo in the spinal cord. These hypotheses will be tested by accomplishing the following specific
aims:
Aim #1: To measure the chemical shift of glycine in-vitro under physiological conditions using
CEST imaging.
Aim #2: To determine the effect that concentration, pH, static magnetic field, B1 field strength
and saturation time have on the chemical exchange of glycine.
Aim #3: To demonstrate, at varying static magnetic field strengths, that the chemical shift of
glycine can provide contrast on T1¿weighted images and that at ultra-high static fields it shows
greater sensitivity than the CEST effect.
Aim #4: To measure glycine concentrations non-invasively in-vivo in rat models using CEST and
T1¿weighted images.
这个子项目是利用资源的许多研究子项目之一。
由NIH/NCRR资助的中心拨款提供。对子项目的主要支持
子项目的首席调查员可能是由其他来源提供的,
包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能
表示该子项目使用的中心基础设施的估计数量,
不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。
病理过程影响某些代谢物或神经递质的浓度以及
局部环境,如酸碱度和血流量。甘氨酸是一种神经递质,它作为一种
中枢神经系统中重要的抑制性神经递质。甘氨酸依赖突触
被发现高度集中在脑干、视网膜和脊髓。在场和
甘氨酸受体的位置表明甘氨酸信号可能在神经中起关键作用。
许多运动和认知疾病的病理学;一些值得注意的例子包括肌营养不良
侧索硬化症(ALS)、帕金森氏病、多动症和阵发性运动。
对这些因素进行侵入性测量是困难的,并且可能对患者造成比
利益。虽然磁共振波谱(MRS)以前被用来测量
中枢神经系统(CNS)的神经递质浓度,这项技术缺乏
足够的空间分辨率可用于常规临床研究。衡量这一点的能力
在高分辨率下的非侵入性方面将是诊断的一个重大突破
这些和许多其他的障碍。蛋白质不稳定质子与水之间的化学交换
质子可以使核磁共振成像(MRI)主要用于探测块状物质
水分信号,对关于内源蛋白质浓度和它们的信息的敏感
环境。最近,一种名为化学交换依赖饱和转移的技术
(CEST),它通过磁化交换来衰减散装水的磁化
与饱和的不稳定质子,已被用来表征稀易变基团的性质。而当
CEST研究已经探索了许多代谢物,但还没有研究表明
甘氨酸的CEST效应。旋转标架中的自旋-晶格弛豫是另一个对比
依靠化学交换的技术。
到目前为止,还没有使用T1来对比质子化学交换的研究。
T_1?化学交换效应随静磁场的变化呈二次曲线变化。因此,T1?
在探测交换介导的相互作用时,可能在更高的领域提供更高的灵敏度
核自旋系统。T1?MRI的这种更高的灵敏度可以使代谢物的检测成为可能
在大脑中的浓度很低(~1 mM)。
我们假设在较高磁场下量化甘氨酸的CEST效应是可能的
(E3T)。此外,T1?MR成像对质子化学交换的敏感度高于
超高静电场下的CEST方法最后,我们认为测定甘氨酸是可行的。
在脊髓的活体内。这些假设将通过完成以下具体任务来检验
目标:
目的#1:测定生理条件下甘氨酸的体外化学位移
CEST成像。
目的#2:测定浓度、pH值、恒磁场、B1场强对
饱和时间对甘氨酸的化学交换有影响。
目标#3:证明在不同的静磁场强度下,化学位移
甘氨酸可以在T1加权图像上提供对比度,在超高静电场下可以显示出对比度
比CEST效应更敏感。
目的#4:用CEST和CEST无创测定大鼠体内甘氨酸浓度
T1?加权图像。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FELIKS KOGAN其他文献
FELIKS KOGAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FELIKS KOGAN', 18)}}的其他基金
QUANTIFICATION OF METABOLITES WITH EXCHANGEABLE PROTONS USING SPIN-LOCK MRI
使用自旋锁 MRI 对可交换质子代谢物进行定量
- 批准号:
8361972 - 财政年份:2011
- 资助金额:
$ 3.84万 - 项目类别:
COMBINING CEST AND SPIN-LOCK TECHNIQUES TO STUDY INTERMEDIATE CHEMICAL EXCHANGE
结合 CEST 和自旋锁技术研究中间化学交换
- 批准号:
8361999 - 财政年份:2011
- 资助金额:
$ 3.84万 - 项目类别:
PROTON TRANSFER IMAGING OF GLYCINE IN THE SPINAL CORD
脊髓中甘氨酸的质子转移成像
- 批准号:
8169067 - 财政年份:2010
- 资助金额:
$ 3.84万 - 项目类别:
QUANTIFICATION OF METABOLITES WITH EXCHANGEABLE PROTONS USING SPIN-LOCK MRI
使用自旋锁 MRI 对可交换质子代谢物进行定量
- 批准号:
8169061 - 财政年份:2010
- 资助金额:
$ 3.84万 - 项目类别:
QUANTIFICATION OF CEST CONTRAST AGENT CONCENTRATION USING PROTON SPIN-LOCK MRI
使用质子自旋锁 MRI 量化 CEST 造影剂浓度
- 批准号:
7955344 - 财政年份:2009
- 资助金额:
$ 3.84万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Fellowship














{{item.name}}会员




